| MFFAIS Mutual Fund Facts About Individual Stocks |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Trading By Perceptive Advisors Llc |
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
| Hypotheticals use the owners holdings and changes reported as a model portfolio combining with stock price changes between the base price date and end price date. All results/returns are hypothetical and are not actual results! | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Worst Move: | Lost $-5,333,212 on changes made with Medivation Inc (MDVN) buying shares when price went down. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Best Move: | Made $14,934,759 on changes made with Intermune Inc (ITMN) buying shares when price went up. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Best Save: | Saved $-5,049,000 on changes made with Osi Pharmaceuticals Inc (OSIP) selling shares when price went down. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Missed Move: | Missed $315,000 on changes made with Amag Pharmaceuticals Inc (AMAG) selling shares when price went up. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Perceptive Advisors Llc Stock Trading |
| Transactions: Currently showing holdings/transactions Filed between 2009-11-18 and 2010-02-16 |
| Prices: Currenty using base stock prices on Filing Date compared to stock prices on 2010-03-19 |
| Filed | As-Of/On | Form | FullName | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Symbol | Country | Industry | Shares | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Activity | Shares Change | Shares Change Pct. | Hypothetical Old Value | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Hypothetical New Value | Hypothetical Value Change | Hypothetical Return | Hypothetical Results | Director | Ten Pct | Other | Officer | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Officer Title | History | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results | Director | Other | Ten Pct | Officer | Officer Title | History |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2010-02-16 | 2009-12-31 | 13F-HR | Penwest Pharmaceuticals Co | PPCO | US | Drug Delivery Systems | 6,476,446 | Added More | 1,850,000 | 39.98 % | $15,932,057 | $22,797,090 | $6,865,033 | 43.08 % | $1,961,000 | History of Perceptive Advisors Llc Ownership Of Penwest Pharmaceuticals Co | |||||
| 2010-02-16 | 2009-12-31 | 13F-HR | Poniard Pharmaceuticals Inc | PARD | BE | Medical-Drugs | 2,050,000 | Sold Some | -1,476,300 | -41.86 % | $3,300,500 | $3,198,000 | $-102,500 | -3.10 % | $73,815 | History of Perceptive Advisors Llc Ownership Of Poniard Pharmaceuticals Inc | |||||
| 2010-02-16 | 2009-12-31 | 13F-HR | Amylin Pharmaceuticals Inc | AMLN | US | Therapeutics | 1,200,000 | Added More | 1,000,000 | 500.00 % | $21,780,000 | $26,988,000 | $5,208,000 | 23.91 % | $4,340,000 | History of Perceptive Advisors Llc Ownership Of Amylin Pharmaceuticals Inc | |||||
| 2010-02-16 | 2009-12-31 | 13F-HR | Genvec Inc | GNVC | US | Medical-Biomedical/Gene | 0 | Sold All | -950,000 | -100 % | - | - | - | 17.08 % | $-389,500 | History of Perceptive Advisors Llc Ownership Of Genvec Inc | |||||
| 2010-02-16 | 2009-12-31 | 13F-HR | Supergen Inc | SUPG | US | Medical-Biomedical/Gene | 864,227 | New Holding | 864,227 | 100 % | $2,480,331 | $2,800,095 | $319,764 | 12.89 % | $319,764 | History of Perceptive Advisors Llc Ownership Of Supergen Inc | |||||
| 2010-02-16 | 2009-12-31 | 13F-HR | Vivus Inc | VVUS | US | Therapeutics | 513,000 | Sold Some | -859,000 | -62.60 % | $4,447,710 | $4,514,400 | $66,690 | 1.49 % | $-111,670 | History of Perceptive Advisors Llc Ownership Of Vivus Inc | |||||
| 2010-02-16 | 2009-12-31 | 13F-HR | Cell Therapeutics Inc | CTIC | US | Medical-Biomedical/Gene | 1,300,000 | Added More | 850,000 | 188.88 % | - | - | - | - % | History of Perceptive Advisors Llc Ownership Of Cell Therapeutics Inc | ||||||
| 2010-02-16 | 2009-12-31 | 13F-HR | Wyeth | WYE | US | Medical-Drugs | 0 | Sold All | -775,000 | -100 % | - | - | - | - % | History of Perceptive Advisors Llc Ownership Of Wyeth | ||||||
| 2010-02-16 | 2009-12-31 | 13F-HR | Avi Biopharma Inc | AVII | US | Therapeutics | 2,841,019 | Added More | 630,000 | 28.49 % | $4,147,888 | $3,664,915 | $-482,973 | -11.64 % | $-107,100 | History of Perceptive Advisors Llc Ownership Of Avi Biopharma Inc | |||||
| 2010-02-16 | 2009-12-31 | 13F-HR | Intermune Inc | ITMN | US | Medical-Biomedical/Gene | 956,396 | Added More | 594,300 | 164.12 % | $14,967,597 | $39,001,829 | $24,034,231 | 160.57 % | $14,934,759 | History of Perceptive Advisors Llc Ownership Of Intermune Inc |
| Form Type | Filed | As-Of/On | Sec Filename | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13F-HR | 2010-02-16 | 2009-12-31 | edgar/data/1224962/0000909012-10-000152.txt | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss! There has been no adjustmentsfor splits! | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate! | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2005 All rights reserved. Please see our Terms of Use. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||